SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-24-084914
Filing Date
2024-08-01
Accepted
2024-08-01 16:17:22
Documents
1
Group Members
5AM OPPORTUNITIES II (GP), LLC5AM OPPORTUNITIES II, L.P.5AM PARTNERS VI, LLCANDREW J. SCHWABKUSH PARMAR

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2420635d1_sc13g.htm SC 13G 123502
  Complete submission text file 0001104659-24-084914.txt   125245
Mailing Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107
Business Address 501 2ND STREET, SUITE 350 SAN FRANCISCO CA 94107 (415) 993-8565
5AM Ventures VI, L.P. (Filed by) CIK: 0001753037 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121
Business Address 5505 MOREHOUSE DRIVE SAN DIEGO CA 92121 (858) 267-4467
Artiva Biotherapeutics, Inc. (Subject) CIK: 0001817241 (see all company filings)

IRS No.: 863614316 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-94570 | Film No.: 241166960
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)